Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Ovarian Neoplasms 1Osteoporosis, Postmenopausal 1Neoplasms 1Endometrial Neoplasms 1

Interventions

Resistance Training 2tibolone 1Weights and Measures 1Risedronic Acid 1LY 353381 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Osteoporosis, Postmenopausal × LY 353381 × Clear all
NCT00088010 2010-06-02

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Eli Lilly and Company

Phase 3 Completed
9,369 enrolled

Osteoporosis, Postmenopausal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡